About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Schizophrenia Clinical Trials in Philadelphia | 153 Studies

Clinical Trials SchizophreniaPhiladelphia

Schizophrenia Clinical Trials in Philadelphia

Find 153 clinical trials for schizophrenia near Philadelphia, Pennsylvania. Connect with research centers in your area.

All Schizophrenia trials nationwide All trials in Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 1-20 of 153 trials

CompletedComparison of Intramuscular Olanzapine Depot With Placebo in the Treatment of Patients With SchizophreniaKey objectives of this clinical study are to: * Determine how well intramuscular (IM) olanzapine depot works compared to placebo * Evaluate the safety and tolerability of IM…NCT00088478·National City, California and 36 others

Schizophrenia Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix San Antonio

Data from ClinicalTrials.govTerms

CompletedLurasidone Low-Dose - High-Dose Study StudyThe primary purpose of this study is to evaluate the efficacy of lurasidone 20 mg/day in subjects with an acute exacerbation of schizophrenia.NCT01821378·Little Rock, Arkansas and 65 others

CompletedLurasidone HCl: A Phase 3 Study of Patients With Acute SchizophreniaLurasidone HCl is a compound being developed for the treatment of schizophrenia.NCT00549718·Little Rock, Arkansas and 47 others

CompletedA 6 Month Study to Compare the Metabolic Effects of Paliperidone ER and Olanzapine in Patients With SchizophreniaThe purpose of this 6 month study is to compare the metabolic effects of paliperidone ER and olanzapine in patients with schizophrenia, using the ratio of the concentration of…NCT00645099·Buenos Aires and 45 others

CompletedStudy of EVP-6124 (Alpha-7 nAChR) as an Adjunctive Pro-Cognitive Treatment in Schizophrenia Subjects on Chronic Stable Atypical Antipsychotic TherapyThe purpose of this study is to determine if EVP-6124 (an alpha-7 nAChR agonist) enhances the cognitive abilities of subjects with Schizophrenia who are also taking stable…NCT01714661·Tucson, Arizona and 93 others

CompletedA Study of ALKS 3831 in Adults With SchizophreniaThis is a Phase 2, randomized, placebo-controlled multicenter study, which will be conducted in 2 parts.NCT01903837·Little Rock, Arkansas and 60 others

CompletedA Study to Test the Safety and Tolerability of a New Medication in the Treatment of SchizophreniaA 1-year outpatient study to test the safety and tolerability of a new medication in the treatment of schizophreniaNCT00088621·Birmingham, Alabama and 20 others

CompletedLurasidone Pediatric Pharmacokinetics StudyThis is a Phase 1, open-label, multicenter, single and multiple ascending lurasidone dose study in subjects from 6 to 17 years old with schizophrenia spectrum, bipolar spectrum…NCT01620060·Little Rock, Arkansas and 9 others

CompletedA 26-Week Extension Study of EVP-6124 (Alpha-7 nAChR) as an Adjunctive Pro-Cognitive Treatment in Schizophrenia Subjects on Chronic Stable Atypical Antipsychotic TherapyThis study is being conducted to further investigate the safety of prolonged exposure to EVP-6124 in subjects with Schizophrenia receiving a stable dose of an atypical…NCT01714713·Little Rock, Arkansas and 127 others

UnknownStudy to Evaluate the Safety and Efficacy of MEM 3454 as Adjunctive Treatment in Combination With a Preexisting Antipsychotic in Patients With Cognitive Impairment Associated With SchizophreniaTo establish the proof of concept that MEM 3454, used as add-on pharmacotherapy, is a safe and effective treatment in patients with cognitive impairment associated with…NCT00604760·Lemon Grove, California and 43 others

CompletedProof of Concept Study of Cognitive Improvement in Patients With SchizophreniaThe purpose of this study is to demonstrate that AZD3480 improves cognition in patients with stable schizophrenia who are being treated with an atypical antipsychotic and who are…NCT00528905·Little Rock, Arkansas and 79 others

CompletedMulticenter, Open-label, Safety and Tolerability StudyThis will be a multicenter, 52 week, open label study to assess the safety and tolerability of oral OPC-34712 (1 to 6 mg) as monotherapy in adult patients with schizophrenia.NCT01649557·Little Rock, Arkansas and 67 others

UnknownEvaluating Sublingual Dexmedetomidine For Moderate To Severe Agitation In Inpatients With Schizophrenia Or Bipolar DisorderAn open-label, randomized, active control inpatient trial to evaluate the efficacy and tolerability of sublingual dexmedetomidine for the treatment of agitation in inpatients with…NCT06093451·Philadelphia, Pennsylvania

TerminatedA Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic FeaturesApproximately 450 patients will be randomized to receive mifepristone or placebo for 7 days followed by antidepressant.NCT00637494·Little Rock, Arkansas and 41 others

CompletedOpen Label Extension Study of BifeprunoxA one year extension study using flexible doses, 20 or 30 mg daily, of open-label bifeprunox.NCT00366171·Little Rock, Arkansas and 82 others

CompletedEvaluation of A Mindfulness Resiliency Training Program for Refugees Living in JordanTo estimate the efficacy of a structured, scalable and replicable psychosocial intervention targeting refugees living in Jordan, Amman who have been forced to flee their homes due…NCT03760627·Amman

CompletedStudy of Alternate Formulation of Aripiprazole in Agitated Patients With Schizophrenic DisordersStudy to learn if the alternate formulation is effective in agitated schizophrenic patientsNCT00036127·Anaheim, California and 15 others

Completed15 Month Study for Adults Who Have Been Diagnosed With Schizophrenia and IncarceratedThe study will assess the use of paliperidone palmitate compared with oral antipsychotic treatment in delaying time to a protocol-defined treatment failure over 15 months, in…NCT01157351·Bullhead City, Arizona and 55 others

CompletedA Clinical Study to Evaluate the Bioavailability Between Two Products Containing Paliperidone 100 mg in the Form of a Prolonged Release Suspension for Injection in Patients With Schizophrenia Who Are Already Stabilized in This TreatmentThis clinical study will compare the equivalence of two products containing Paliperidone 100 mg in the form of a prolonged release suspension for injection in patients affected by…NCT03425552·Amman and 2 others

CompletedOpen-label, Extension Study of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in Patients With SchizophreniaThe phase 3 Trial 31-12-291 is part of the aripiprazole IM depot clinical development program and has been designed to demonstrate the efficacy and safety of aripiprazole IM depot…NCT01683058·Little Rock, Arkansas and 37 others

Page 1 of 8Next

Other Conditions in Philadelphia

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia